Bellevue Group Ag Illumina, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Illumina, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 45,196 shares of ILMN stock, worth $6.15 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

45,196

Previous 43,596 3.67%

Holding current value

$6.15 Million

Previous $4.55 Million 29.52%

% of portfolio

0.1%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $168,448 - $217,440	1,600 Added 3.67%	45,196 $5.89 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $178,438 - $205,638	-1,397 Reduced 3.1%	43,596 $5.99 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $2.51 Million - $3.85 Million	-27,037 Reduced 37.54%	44,993 $6.26 Million
Q3 2023 Nov 14, 2023	SELL	$128.91 - $192.44 $1.55 Million - $2.31 Million	-11,996 Reduced 14.28%	72,030 $9.89 Million
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $2.79 Million - $3.54 Million	-15,231 Reduced 15.35%	84,026 $15.8 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $842,812 - $1.01 Million	4,350 Added 4.58%	99,257 $23.1 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $1.68 Million - $2.18 Million	8,980 Added 10.45%	94,907 $19.2 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $166,596 - $213,793	-940 Reduced 1.08%	85,927 $16.4 Million
Q2 2022 Aug 11, 2022	BUY	$181.58 - $368.0 $1.45 Million - $2.94 Million	7,986 Added 10.12%	86,867 $16 Million
Q1 2022 May 13, 2022	BUY	$303.87 - $423.8 $1.14 Million - $1.59 Million	3,751 Added 4.99%	78,881 $27.6 Million
Q4 2021 Feb 10, 2022	BUY	$347.28 - $421.83 $1.74 Million - $2.11 Million	5,000 Added 7.13%	75,130 $28.6 Million
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $2.11 Million - $2.73 Million	-5,200 Reduced 6.9%	70,130 $28.4 Million
Q2 2021 Aug 12, 2021	BUY	$372.84 - $481.5 $5.37 Million - $6.94 Million	14,412 Added 23.66%	75,330 $35.6 Million
Q1 2021 May 12, 2021	BUY	$361.28 - $504.76 $3.09 Million - $4.32 Million	8,552 Added 16.33%	60,918 $23.4 Million
Q4 2020 Feb 16, 2021	SELL	$292.7 - $370.96 $1.81 Million - $2.29 Million	-6,181 Reduced 10.56%	52,366 $19.4 Million
Q3 2020 Nov 16, 2020	SELL	$268.51 - $400.74 $10.1 Million - $15 Million	-37,500 Reduced 39.04%	58,547 $18.1 Million
Q2 2020 Aug 13, 2020	SELL	$256.46 - $373.01 $26.4 Million - $38.4 Million	-102,941 Reduced 51.73%	96,047 $35.6 Million
Q1 2020 May 14, 2020	SELL	$209.2 - $335.53 $4.74 Million - $7.61 Million	-22,679 Reduced 10.23%	198,988 $54.3 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $4.13 Million - $4.81 Million	14,335 Added 6.91%	221,667 $73.5 Million
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $5.57 Million - $7.89 Million	-20,859 Reduced 9.14%	207,332 $63.1 Million
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $8.87 Million - $10.9 Million	-29,505 Reduced 11.45%	228,191 $84 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $1.58 Million - $1.86 Million	5,803 Added 2.3%	257,696 $80.1 Million
Q4 2018 Feb 12, 2019	BUY	$272.46 - $366.54 $28.4 Million - $38.2 Million	104,186 Added 70.54%	251,893 $75.6 Million
Q3 2018 Nov 13, 2018	BUY	$279.04 - $367.06 $1.88 Million - $2.47 Million	6,736 Added 4.78%	147,707 $54.2 Million
Q2 2018 Aug 07, 2018	BUY	$228.17 - $292.07 $3.13 Million - $4 Million	13,698 Added 10.76%	140,971 $39.4 Million
Q1 2018 May 09, 2018	SELL	$209.54 - $253.91 $4.74 Million - $5.74 Million	-22,600 Reduced 15.08%	127,273 $30.1 Million
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $2.76 Million - $3.14 Million	-13,652 Reduced 8.35%	149,873 $32.7 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $9.49 Million - $11.8 Million	55,060 Added 50.76%	163,525 $32.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	108,465	108,465 $18.8 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Illumina, Inc. Transaction History